# The Active Implantable Medical Devices Regulations 1992, Paragraph 10: Requirements as to design and construction


Where a device incorporates, as an integral part, a substance which, when used separately, is likely to be considered to be a medicinal product as defined in Article 1 of Directive 65/65/EEC, and whose action in combination with the device may result in its bioavailability, the safety, quality and usefulness of the substance, account being taken of the purpose of the device, must be verified by analogy with the appropriate methods specified in Directive 75/318/EEC, as last amended by Directive 91/507/EEC.

---
Source: https://www.legislation.gov.uk/uksi/1992/3146/schedule/2/paragraph/10 (the official version)
Page: https://openlegislation.uk/active-implantable-medical-devices-regulations-1992/schedule-2/paragraph-10
Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives.